top of page
Jan 302 min read
Granules strengthens ADHD portfolio with FDA approval for Lisdexamfetamine Dimesylate Capsules
Granules India received the final approval from the US FDA for its ANDA for Lisdexamfetamine Dimesylate Capsules in strengths of 10-70 mg
bottom of page